Jianjing Liu

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy.

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy.

Journal: Journal for immunotherapy of cancer

Published: February 18, 2026

First-in-human evaluation of four novel PSMA-targeted PET radiotracers with non-canonical amino acid linkage: A comparative study.

First-in-human evaluation of four novel PSMA-targeted PET radiotracers with non-canonical amino acid linkage: A comparative study.

Journal: Pharmacological research

Published: January 22, 2026

Optimized CDK19 PET Tracers: Spirocyclic-Driven Design and Prostate Cancer Imaging.

Optimized CDK19 PET Tracers: Spirocyclic-Driven Design and Prostate Cancer Imaging.

Journal: Journal of medicinal chemistry

Published: July 18, 2025

Efficacy and safety of anlotinib in combination with ¹³¹I therapy in the treatment of distant metastatic differentiated thyroid cancer: a single-arm, phase II study.

Efficacy and safety of anlotinib in combination with ¹³¹I therapy in the treatment of distant metastatic differentiated thyroid cancer: a single-arm, phase II study.

Journal: Frontiers in oncology

Published: May 04, 2025

Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer.

Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer.

Journal: Frontiers in oncology

Published: April 30, 2024

Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results.

Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results.

Journal: European journal of radiology

Published: June 02, 2022

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma.

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma.

Journal: Frontiers in genetics

Published: September 07, 2021

Molecular subtype classification of breast cancer using established radiomic signature models based on 18F-FDG PET/CT images.

Molecular subtype classification of breast cancer using established radiomic signature models based on 18F-FDG PET/CT images.

Journal: Frontiers in bioscience (Landmark edition)

Published: July 05, 2021

Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.

Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.

Journal: Gland surgery

Published: April 12, 2021

SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.

SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.

Journal: International journal of biological sciences

Published: March 18, 2021

Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.

Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.

Journal: International journal of medical sciences

Published: January 15, 2021

18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model.

18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model.

Journal: OncoTargets and therapy

Published: July 10, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026